Samsara Biocapital LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Samsara Biocapital LLC
CRD #288114
SEC #801-113741
CIK #0001744967
AUM 2,170.1 M (2026-06-26)
Employees 31 (71% Investors, 0% Brokers)
Fees
Minimum
Phone650-285-4270
Address
Source [IAPD] [EDGAR] [Website] [Twitter]
Total AUM ($B)
3.02.41.81.20.60.02010201520212027
Fees and Compensation — Form ADV Part 2A (3/31/2026) [Brochure]
FEES AND COMPENSATION

A. Advisory Fees and Compensation.
Investors and prospective investors should refer to the Governing Documents of a Fund for a detailed
description of the fees.

The Funds generally compensate Samsara with a management fee based on a combination of committed
capital, the cost basis of certain investments then-owned by each Fund and in some cases the net assets of
the Fund (the “Management Fee”). In addition, performance-based compensation, based on the net
profits allocated to each investor and calculated on a high watermark basis (the “Incentive Allocation”), is
allocated to the applicable GP Entity. Samsara may waive the Management Fee and Incentive Allocation
for investors that are partners or employees of Samara or the GP Entities. Otherwise, the Management
Fee and Incentive Allocation are generally not negotiable.
B. Payment of Fees.
Samsara deducts fees directly from a Fund’s assets. Investors do not have the ability to choose to be
billed directly for fees. Management Fees are generally deducted quarterly in advance as specified in the
Governing Documents. The Incentive Allocation is paid to the applicable GP Entity when earned.

C. Other Fees and Expenses.
As set forth in the Governing Documents, each Fund bears all costs and expenses incurred in the holding,
purchase, sale or exchange of securities (whether or not ultimately consummated), including, but not by
way of limitation, private placement fees, finder’s fees, interest on borrowed money, real property or
personal property taxes on investment, including documentary, recording, stamp and transfer taxes,
brokerage fees or commissions, legal fees, legal and compliance expenses (including expenses related to
regulatory filings, blue sky and corporate filing fees, expenses incurred in connection with the
investigation prosecution or defense of any claims by or against the Fund, including claims or
investigations by or against a governmental authority, audit and accounting fees (including custody audit,
if any), third-party consulting fees relating to investments or proposed investments, taxes applicable to the
Fund on account of its operations, fees incurred in connection with the maintenance of bank or custodian
accounts, and all expenses incurred in connection with the registration of the Fund’s securities under
applicable securities laws or regulations. Each Fund also bears expenses incurred by the GP Entity in
serving as partnership representative, the reasonable cost of liability and other premiums for insurance
protecting the Fund, the GP Entity, the members, and Samsara and its employees from liability to third
parties (including directors & officers and errors & omissions insurance costs) arising out of or related to
the affairs of the Fund, all out-of-pocket expenses of preparing and distributing reports to investors, out-
of-pocket expenses associated with Fund communications with investors, including preparation of annual
or other reports to the limited partners, out-of-pocket costs associated with Fund meetings or advisory
committee matters, all legal, accounting and administrator fees relating to the Fund and its activities, all
costs and expenses arising out of the Fund’s indemnification obligation, and any other expenses related to
the purchase, sale or transmittal of Fund assets.

Each Fund also bears all organizational and syndication costs, fees, and expenses by or on behalf of the
GP Entity in connection with the formation and organization of the Fund and the GP Entity, including
legal and accounting fees and expenses subject to the terms and limitations set for in the Fund’s
Governing Document.

Each Fund may be deemed to be paying for research and other services with bundled commission
arrangements including soft dollars. Refer to Item 12 – Brokerage Practices for further information.

Samsara, the GP Entities, or their members, or employees may receive management service, advisory,
consultant, transaction, break-up or broken deal fees, or similar fees from Portfolio Companies, and 100%
of such fees will offset the Management Fees payable to Samsara. In addition, Samsara, the GP Entities,
or their members, or employees may receive director or consulting fees from Portfolio Companies in the
form of cash, restricted or unrestricted stock or stock options (“Board Fees”). Any Board Fees in excess
of $100,000 per year per Portfolio Company will generally 100% offset the Management Fee payable to
Samsara, subject to the terms of the Governing Documents. These fees, and the associated conflicts of
interest they present, are further described in Item 11 below.

Investors and prospective investors should refer to the Governing Documents of a Fund for
detailed information with respect to the fees and expenses they may pay in connection with an
investment in such Fund. The information contained herein is a summary only and is qualified in
its entirety by such Governing Documents. For further information regarding brokerage
practices, please see “Item 12 – Brokerage Practices.”
D. Prepayment of Fees.
Management Fees are generally paid quarterly in advance, as of the first day of each calendar quarter, as
specified in each Fund’s Governing Documents. Upon termination of investment management services,
Management Fees that have been prepaid are returned on a prorated basis.

E. Additional Compensation and Conflicts of Interest.
Samsara does not accept compensation for the sale of securities or other investment products, including
asset-based sales charges or service fees.
Account Minimums and Types of Clients — Form ADV Part 2A (3/31/2026) [Brochure]
TYPES OF CLIENTS

Samsara provides investment advisory services to the Funds. All Investors in the Funds are “accredited
investors” (as defined in Regulation D under the Securities Act of 1933, as amended (the “Securities
Act”)), “qualified clients” (as defined in Rule 205-3 under the Advisers Act) and “qualified purchasers”
or “knowledgeable employees” (as defined in section 2(a)(51) of the Investment Company Act of 1940,
amended (“Investment Company Act”) or Rule 3c-5 thereunder)). Admission to the Funds is not open to
the general public.

Samsara does not have a minimum size for a Fund, and minimum investment commitments by Investors
are determined at the discretion of the GP Entities.
Sector Form 13F Holdings Value ($M)
Scholar Rock Holding Corp 339.1
Mineralys Therapeutics Inc 159.0
Alumis Inc 139.8
Septerna Inc 75.7
Allovir Inc 74.7
Spyglass Pharma Inc 54.7
Aquinox Pharmaceuticals Inc 34.6
Inventiva Sa 28.8
Aerovate Therapeutics Inc 13.6
VTV Therapeutics Inc 11.8
View All
Holdings by Sector ($M)
110088066044022002017202020232027
Type Form D Funds Date Sold AUM
VC Samsara Opportunity Fund LP [2026-03-31] 98.0 M 270.1 M
Offered $200,000,000 · Filed 2025-09-26 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining $102,028,666 · Duration One year or less · Net Assets Decline to Disclose
VC SMSR B1 LP [2023-03-31] 149.3 M
VC 565 SPV I LP 2020-03-30 0.0 M
VC Samsara Biocapital LP [2017-03-20] 310.1 M 1,900.0 M
Offered $310,090,000 · Filed 2018-04-20 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Duration More than one year · Finder's Fee $20,000 · Revenue Decline to Disclose
AUM Breakdown Accounts AUM ($B)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 3 2.2
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 3 2.2
By Discretionary
Discretionary 3 2.2
Non-Discretionary 0 0.0
Total 3 2.2
By Non-United States Persons
Non-United States Persons 0.2
United States Persons 1.9
Total 3 2.2
Form D Directors Role # Filings # Firms 2011 - 2026
Srinivas Akkaraju Director 28 3
Michael Dybbs Director 16 2
Abraham Bassan Director 5 2
Abrar Hussain Executive Officer 4 2
Samsara Biocapital GP LLC Director 2 2
Samsara Opportunity Fund GP LLC Director 1 1
Miran Ahmad Executive Officer 1 1
EDGAR Form CIK 2011 - 2026
13F-HR [0001744967]
Firm Profile (Form ADV)
ServesInstitutional
Comparable Firms State AUM
Clearbridge Investments North America PTY Limited
2,228.1 M
FS Structured Products Advisor LLC
PA 2,203.9 M
Bell Asset Management Limited
2,176.8 M
Lattice Strategies LLC
PA 2,153.5 M
Lawley Retirement Advisors LLC
NY 2,130.1 M
Sparx Asset Management Korea Co Ltd
2,126.2 M
DoubleLine ETF Adviser LP
FL 2,125.6 M
Velocity Capital Advisors LLC
NY 2,115.4 M
New England Retirement Consultants LLC
MA 2,113.8 M
Distillate Capital Partners LLC
IL 2,111.5 M
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com